SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agouron Pharmaceuticals (AGPH)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
6136 24 0 AGPH
Emcee:  Bhag Karamchandani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4836 in defense of the shorts ... phew! I just read thestreet article. ouch! somPeter Singleton-7/10/1998
4835 An investors response to the to the points in the street: <<gph on defenVector1-7/10/1998
4834 Bill, I'd do it, but have used my 2 week free trial. I think they stillSteve Fancy-7/10/1998
4833 Oliver: Thanks for the headline, anyone willing to copy and paste the content billkirn-7/10/1998
4832 Points from TheStreet.com article posted 6;00 pm 7/9/98 "Embattled Agouronsmh-7/10/1998
4831 Top Stories Embattled Agouron CEO Reassures Employees, Investors 7/9/98 6:01 POliver & Co-7/10/1998
4830 smh: Can you relay some of the points made on Street.com? Bill billkirn-7/9/1998
4829 Blistering story on AGPH I'm afraid at thestreet.com smh smh-7/9/1998
4828 nice try John ; ) it Intel Trader-7/9/1998
4827 Ok, thanks for the response. John John F Beule-7/9/1998
4826 The drug which is active against Hep B is lamivudine, a NRTI. Viracept should biodoc-7/9/1998
4825 Another potential use for Viracept? AIDS drug effective against hepatitis B - John F Beule-7/8/1998
4824 "Antiretroviral Therapy for HIV Infection in 1998" Journal of the AmeOliver & Co-7/8/1998
4823 Well, disappointing day. Appearing that AGPH may be establishing a new loweSteve Fancy-7/8/1998
4822 Another potential use for AG3340: "A drug currently undergoing phase IIIJoe E.-7/8/1998
4821 JLL: Just read your post 4818 after I finished mine. Please see "private mIzzy-7/8/1998
4820 Dr. Oliver: Thanks for the post (it's great hearing from you again, altho&#Izzy-7/8/1998
4819 FOR RELEASE , July 6, 1998 Greg Folkers (301) 402-1663 gfolkers@nih.gov ThOliver & Co-7/8/1998
4818 Hi Izzy, I have been reading the posts of the past few days, and watched as AGPOliver & Co-7/8/1998
4817 Online Coverage from the 12th World AIDS Conference June 29 - July 2, 1998 c MeOliver & Co-7/7/1998
4816 Ok Peter, I'll have to let this go for now, however, I want to go on recSteve Fancy-7/7/1998
4815 Yes Robert: I think it is for MacularDegeneration, and a trial has been startebillkirn-7/7/1998
4814 Steve! AG3340 just went into pivotal trials ... 500+ patients, PII/III (leadPeter Singleton-7/7/1998
4813 Intel, could be, but I think at 23 there just were not any more sellers...thSteve Fancy-7/7/1998
4812 To All, In looking at AGPH's 10-K from last year I noticed in the pipelineRobert L. Ray-7/7/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News